BOSTON, March 19, 2026 (GLOBE NEWSWIRE)-- Damora Therapeutics, Inc. (formerly Galecto, Inc.) (“Damora” or the “Company”) (NASDAQ: DMRA), a biotechnology company working to fundamentally redefine care ...
-- DMR-001 on track for IND or CTA submission in mid-2026, with two clinical proof-of-concept datasets expected beginning mid-2027 -- -- Strong financial position with approximately $535 million in ...
BOSTON, March 23, 2026 (GLOBE NEWSWIRE)-- Damora Therapeutics, Inc. (NASDAQ: DMRA), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced ...
Use Alt+F4 keyboard shortcut Use Taskkill Kill a Not Responding process using a Shortcut Terminate ALL open applications instantly. Click on the application you want to close and then press the Alt+F4 ...
Investing.com -- Damora Therapeutics Inc (NASDAQ:DMRA) shares jumped 15.5% Monday following the announcement of Jennifer Jarrett as President and Chief Executive Officer, effective March 30, 2026.
Your browser does not support iframes. Our coverage area is an unusual geographic market: the Lehigh Valley and Berks County. It's the third largest business district ...
-- Ms. Jarrett brings nearly three decades of executive leadership in biotech, tech and finance -- -- Biotech leaders Dr. Cameron Turtle and Mike Landsittel appointed to Board of Directors -- -- Peter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results